SIRT6 and neoplasm: In conclusion, the results demonstrated that SIRT6 inhibits TFAM, leading to mitochondrial dysfunction and inducing mitophagy, ultimately suppressing colorectal cancer growth, which were validated in vivo using a mouse xenograft tumor model.